Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin vs Botox in Post-Stroke Spastic Equinovarus Foot
NCT03044080Phase 4Completed
- Sponsor
- Parc de Salut Mar
- Start
- Jan 2015
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in spastic equinovarus foot (SEVF), sponsored by Parc de Salut Mar. Started Jan 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
spastic equinovarus foot (SEVF)
Beyond the preview
Go deeper on NCT03044080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044080.